Office of the Maine Attorney General

Attorney General Mills announces settlement with maker of EpiPen for overbilling taxpayers

AUGUSTA ? Attorney General Janet T. Mills announced today that Maine has agreed in principle to join the United States and other States to settle allegations against Mylan Inc. and its wholly-owned subsidiary, Mylan Specialty L.P. (collectively ?Mylan?). The settlement will resolve allegations that Mylan knowingly underpaid rebates owed to the Medicaid program for the drugs EpiPen? and EpiPen Jr.? (?EpiPen?) dispensed to Medicaid beneficiaries. Under the settlement, Mylan will pay $465 million to the United States and the States. The States will share $213,936,000 of the total settlement.

Attorney General Janet T. Mills announces action to address the opioid crisis

AUGUSTA ? Attorney General Janet T. Mills is working with a bipartisan coalition of Attorneys General from across the country in evaluating the practices of manufacturers of opioids.

The Attorneys General are investigating what role opioid manufacturers may have played in creating or prolonging this epidemic. Since 2010 nearly 800 Mainers have died from an overdose of a pharmaceutical opioid, compared to about 600 who died from an illicit opioid.

Attorney General Mills Urges Eligible Maine Residents to Submit Claims for Provigil Settlement

AUGUSTA ? Attorney General Janet T. Mills urges Maine residents to file claims or make their views known on a multistate settlement that provides $35 million for consumers who paid for the brand-name drug Provigil or generic modafinil from June 24, 2006, to March 31, 2012. The time to file claims or express views on the settlement has been extended to June 25, 2017.

To obtain a claim form, visit www.StateAGProvigilSettlement.com or call 1-877-236-1413.

Attorney General Mills announces settlement in latest action against Volkswagen for emissions scandal

AUGUSTA ? Attorney General Janet T. Mills announced today that Volkswagen AG, Audi AG and Porsche AG, as well as their American subsidiaries, have agreed to pay over $157 million to ten states to settle environmental lawsuits filed last year challenging the companies? secret use of unlawful ?defeat device? software in their vehicles ? software that caused tens of thousands of tons of excess harmful pollutants to be emitted into the air in Maine and other states.

Attorney General Mills announces new public education TV ad combating opioids

AUGUSTA ? Maine Attorney General Janet T. Mills announced today a new television ad warning of the link between prescription painkillers and heroin addiction. The ad is the latest in the ?Dose of Reality? public education campaign launched in 2016. The ad will be made available to Maine broadcasters through the Maine Association of Broadcasters? Public Education Partnership program over the coming months.

Consumers Impacted by Scams Utilizing Western Union May Be Eligible for Restitution Payments

AUGUSTA ? Attorney General Janet Mills requests all Mainers who were scammed out of money and asked to utilize Western Union as a payment method to contact her office as they may be eligible for restitution payments. Under a recent settlement with the federal government consumers may be eligible for some restitution if the payments were sent between 1/1/2004 and 1/19/17.

Attorney General Mills announces joint FTC action against sellers of supplements

AUGUSTA ? Maine Attorney General Janet T. Mills today announced that her office and the Federal Trade Commission have filed a complaint against nine defendants, including three corporations and six individuals, for their roles in a deceptive campaign to sell a joint health supplement and a cognitive health supplement in violation of state and federal laws.

Maine and 19 other States File Federal Antitrust Lawsuit against Heritage Pharmaceuticals, other Generic Drug Companies

AUGUSTA ? Attorney General Janet T. Mills today joined with 19 other state attorneys general in filing a federal lawsuit against generic drug-maker Heritage Pharmaceuticals, Inc., Auribindo Pharma USA, Inc., Citron Pharma, LLC, Mayne Pharma (USA), Inc., Mylan Pharmaceuticals, Inc. and Teva Pharmaceuticals USA, Inc. alleging that they entered into numerous illegal conspiracies to artificially inflate and manipulate prices and reduce competition in the United States for two drugs: doxycycline hyclate delayed release, an antibiotic, and glyburide, an oral diabetes medication.

Attorney General?s statement regarding Legislative Council approval of construction within the Capitol Area

Attorney General Janet T. Mills issued the following statement regarding the statutory requirement for the Legislative Council to approve construction of state buildings within the Capitol Area, which includes the Riverview campus and a proposed new forensic facility:

Subscribe to